Cite
APA Citation
Cohen, E., Postow, M., Sullivan, R., Hong, D., Yeckes-Rodin, H., McCarter, J., Zizlsperger, N., Kutok, J., O'Connell, B., Page, K., Roberts, J., Zhang, H., & Chmielowski, B. (n.d.). 352 Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab. Journal for immunotherapy of cancer, 8, A214–A215. http://access.bl.uk/ark:/81055/vdc_100144718578.0x000006